Hanson McClain Advisors »

Kempharm shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Kempharm (ZVRA) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Kempharm

Tip: Access up to 7 years of quarterly data

All positions including Kempharm held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kempharm by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $322 36 8.97
2025-09-30 $524 55 9.53
2025-06-30 $221 25 8.84

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Hanson McClain Advisors

Top funds holding Kempharm

BlackRock
Woodline Partners
Vanguard Group
Caption Management
Adage Capital Partners GP
Nantahala Capital Management
FMR
State Street Corporation
Geode Capital Management
Legal & General Group
Millennium Management
683 Capital Management
Royce & Associates
D. E. Shaw & Co
Marshall Wace

View all funds holding Kempharm